16.07
price down icon8.22%   -1.44
after-market Handel nachbörslich: 16.07
loading

Invizyne Technologies Inc Aktie (IZTC) Neueste Nachrichten

pulisher
Jan 22, 2025

Invizyne technologies CEO Michael Heltzen buys $20,345 in stock - MSN

Jan 22, 2025
pulisher
Jan 21, 2025

Invizyne technologies CEO Michael Heltzen buys $20,345 in stock By Investing.com - Investing.com Australia

Jan 21, 2025
pulisher
Jan 11, 2025

Investors on Edge! What Invizyne’s Market Entry Means for Biotech’s Future - Jomfruland.net

Jan 11, 2025
pulisher
Dec 16, 2024

Invizyne Technologies Inc.'s (NASDAQ:IZTC) Quiet Period To End on December 23rd - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Invizyne Technologies Inc.’s Quiet Period Set To Expire on December 23rd (NASDAQ:IZTC) - Defense World

Dec 16, 2024
pulisher
Nov 25, 2024

Invizyne Technologies selected for $2 million project to advance SAF capabilities - Biomass Magazine

Nov 25, 2024
pulisher
Nov 22, 2024

Invizyne Technologies Inc trading halted, volatility trading pause - TipRanks

Nov 22, 2024
pulisher
Nov 21, 2024

MDB Capital Holdings Provides Third Quarter 2024 Update - Marketscreener.com

Nov 21, 2024
pulisher
Nov 21, 2024

Invizyne Technologies (IZTC) Income Statement & Balance Sheet 2024 - MarketBeat

Nov 21, 2024
pulisher
Nov 20, 2024

Opening Day: Invizyne Technologies jumps after IPO - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Invizyne technologies CEO acquires shares worth $22,022 By Investing.com - Investing.com Australia

Nov 20, 2024
pulisher
Nov 19, 2024

Invizyne technologies CEO acquires shares worth $22,022 - Investing.com

Nov 19, 2024
pulisher
Nov 19, 2024

Faculty in the News – James Bowie - UCLA – Chemistry and Biochemistry

Nov 19, 2024
pulisher
Nov 19, 2024

Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities - Marketscreener.com

Nov 19, 2024
pulisher
Nov 19, 2024

Invizyne Technologies, Inc. Selects for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities - Marketscreener.com

Nov 19, 2024
pulisher
Nov 19, 2024

Invizyne Technologies Completes IPO, Raises $14 Million in Net Proceeds - Defense World

Nov 19, 2024
pulisher
Nov 17, 2024

Invizyne Technologies (IZTC) Stock Chart and Price History 2024 - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

U.S. IPO Weekly Recap: One Micro-Cap Lists And More Enter Pipeline, As Peak Resources Postpones Its IPO - Seeking Alpha

Nov 16, 2024
pulisher
Nov 14, 2024

Invizyne Technologies Announces Closing of Initial Public Offering - Marketscreener.com

Nov 14, 2024
pulisher
Nov 14, 2024

Invizyne Technologies Completes $15M IPO, Makes NASDAQ Debut Under IZTC | MDBH Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

Invizyne Technologies stock climbs 13% following $15M IPO - MSN

Nov 13, 2024
pulisher
Nov 13, 2024

Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing - GlobeNewswire

Nov 13, 2024
pulisher
Nov 13, 2024

Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing - Quantisnow

Nov 13, 2024
pulisher
Nov 13, 2024

Invizyne Technologies Opens At $11.10, IPO Priced At $8 By Investing.com - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Invizyne Technologies Begins Trading on NASDAQ - GlobeNewswire

Nov 13, 2024
pulisher
Nov 12, 2024

Invizyne Technologies prices $15M U.S. IPO - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024 - The Bakersfield Californian

Nov 12, 2024
pulisher
Nov 12, 2024

Invizyne Technologies prices $15M U.S. IPO (Pending:IZTC.) - Seeking Alpha

Nov 12, 2024
pulisher
Nov 11, 2024

Invizyne Technologies Launches $15M IPO, Sets Nasdaq Debut Under 'IZTC' Symbol | MDBH Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 05, 2024

TSX Health Care Capped Index (TTHC) QuotePress Release - The Globe and Mail

Nov 05, 2024
pulisher
Nov 05, 2024

ULSD NY Harbor (HON24) Quote - The Globe and Mail

Nov 05, 2024
pulisher
Oct 04, 2024

IZTC IPO NewsBiomanufacturing company Invizyne Technologies revises terms ahead of $15 million IPO - Renaissance Capital

Oct 04, 2024
pulisher
Sep 06, 2024

Biomanufacturing company Invizyne Technologies cuts share offering by 13% and adds rights ahead of $15 million IPO - Renaissance Capital

Sep 06, 2024
pulisher
Aug 05, 2024

The cold truth: B100 with Optimus Technologies work at -30 °F - Biodiesel Magazine

Aug 05, 2024
pulisher
Jul 11, 2024

MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies - GlobeNewswire

Jul 11, 2024
pulisher
May 07, 2024

Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq - GlobeNewswire

May 07, 2024
pulisher
Apr 17, 2024

MDB Capital Holdings Year-End Update - GlobeNewswire

Apr 17, 2024
pulisher
Feb 12, 2024

Invizyne Technologies Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq - GlobeNewswire

Feb 12, 2024
pulisher
Nov 08, 2023

Michael Burns Joins Invizyne as Executive Vice President of Energy Transition - GlobeNewswire

Nov 08, 2023
pulisher
Oct 17, 2023

Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort - GlobeNewswire

Oct 17, 2023
pulisher
Oct 11, 2023

Invizyne Awarded Additional $3.77 Million Grant from U.S. Department of Energy - GlobeNewswire

Oct 11, 2023
pulisher
Sep 20, 2023

MDBHMDB Capital Holdings, LLC Latest Stock News & Market Updates - StockTitan

Sep 20, 2023
pulisher
Jun 14, 2023

Japan plans to implement SAF mandate by 2030 - Biodiesel Magazine

Jun 14, 2023
pulisher
May 02, 2023

Cavitation Technologies to supply LPN system to biodiesel plant - Biodiesel Magazine

May 02, 2023
pulisher
Jan 16, 2022

Haldor Topsoe technology to be installed at 2 SAF biorefineries - Biodiesel Magazine

Jan 16, 2022
pulisher
Apr 12, 2016

Major advance in biochemistry holds promise for biofuels - University of California

Apr 12, 2016
pulisher
Apr 11, 2016

Major advance in ‘synthetic biochemistry’ holds promise for industrial products and biofuels - UCLA Newsroom

Apr 11, 2016
$79.95
price down icon 1.03%
$20.11
price down icon 2.71%
$347.71
price down icon 1.71%
$4.69
price down icon 6.94%
biotechnology ONC
$223.50
price down icon 2.35%
$117.61
price down icon 1.94%
Kapitalisierung:     |  Volumen (24h):